Russell Investments Group’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.43M Buy
131,749
+118,105
+866% +$5.77M 0.01% 1070
2025
Q1
$695K Sell
13,644
-157,053
-92% -$8M ﹤0.01% 2181
2024
Q4
$7.71M Sell
170,697
-61,542
-26% -$2.78M 0.01% 942
2024
Q3
$8.62M Sell
232,239
-48,861
-17% -$1.81M 0.01% 897
2024
Q2
$8.6M Sell
281,100
-20,690
-7% -$633K 0.01% 885
2024
Q1
$8.78M Buy
301,790
+110,670
+58% +$3.22M 0.01% 884
2023
Q4
$5.27M Sell
191,120
-29,319
-13% -$808K 0.01% 1109
2023
Q3
$4.94M Buy
220,439
+30,803
+16% +$690K 0.01% 1086
2023
Q2
$7.71M Sell
189,636
-50,280
-21% -$2.04M 0.01% 896
2023
Q1
$11.6M Sell
239,916
-5,663
-2% -$274K 0.02% 704
2022
Q4
$9.37M Buy
245,579
+9,497
+4% +$363K 0.02% 786
2022
Q3
$11.8M Sell
236,082
-10,853
-4% -$545K 0.03% 685
2022
Q2
$9.89M Buy
246,935
+27,944
+13% +$1.12M 0.02% 782
2022
Q1
$8.17M Sell
218,991
-24,861
-10% -$927K 0.01% 916
2021
Q4
$9.71M Buy
243,852
+22,462
+10% +$895K 0.02% 910
2021
Q3
$8.24M Buy
221,390
+43,000
+24% +$1.6M 0.01% 978
2021
Q2
$7.54M Buy
178,390
+93,674
+111% +$3.96M 0.01% 1089
2021
Q1
$4.01M Buy
84,716
+19,152
+29% +$907K 0.01% 1471
2020
Q4
$4M Sell
65,564
-15,278
-19% -$932K 0.01% 1362
2020
Q3
$3.78M Sell
80,842
-14,535
-15% -$679K 0.01% 1303
2020
Q2
$4.84M Buy
95,377
+19,960
+26% +$1.01M 0.01% 1112
2020
Q1
$3.36M Buy
75,417
+928
+1% +$41.4K 0.01% 1176
2019
Q4
$3.58M Buy
74,489
+16,088
+28% +$772K 0.01% 1409
2019
Q3
$1.98M Buy
58,401
+48,879
+513% +$1.65M ﹤0.01% 1692
2019
Q2
$428K Hold
9,522
﹤0.01% 2310
2019
Q1
$358K Hold
9,522
﹤0.01% 2455
2018
Q4
$327K Hold
9,522
﹤0.01% 2458
2018
Q3
$448K Hold
9,522
﹤0.01% 2437
2018
Q2
$321K Hold
9,522
﹤0.01% 2533
2018
Q1
$258K Hold
9,522
﹤0.01% 2621
2017
Q4
$159K Hold
9,522
﹤0.01% 2707
2017
Q3
$191K Hold
9,522
﹤0.01% 2675
2017
Q2
$175K Sell
9,522
-13,500
-59% -$248K ﹤0.01% 2716
2017
Q1
$227K Sell
23,022
-13,056
-36% -$129K ﹤0.01% 2670
2016
Q4
$403K Buy
+36,078
New +$403K ﹤0.01% 2538